What's New on the FDA Drugs Site
May 26, 2016
- FDA approves Probuphine, the first buprenorphine implant for treatment of opioid dependence
- FDA Drug Safety Podcast: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated)
- Neonatal opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine
No hay comentarios:
Publicar un comentario